Barnadas, A <br/><br/>
Exemestane as primary treatment of oestrogen receptor-positive breast cancer in postmenopausal women: a phase II trial.  [electronic resource] 

 -  British journal of cancer  Feb 2009 
 - 442-9 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article 
<br/><br/><label>ISSN: </label>1532-1827 
<br/><br/><label>Standard No.: </label>10.1038/sj.bjc.6604868  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Androstadienes--therapeutic use<br/>Antineoplastic Agents--therapeutic use<br/>Aromatase Inhibitors--therapeutic use<br/>Breast Neoplasms--drug therapy<br/>Combined Modality Therapy<br/>Disease Progression<br/>Female<br/>Humans<br/>Middle Aged<br/>Postmenopause<br/>Receptors, Estrogen--metabolism<br/>Survival Analysis